1. Home
  2. GNFT vs JFIN Comparison

GNFT vs JFIN Comparison

Compare GNFT & JFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • JFIN
  • Stock Information
  • Founded
  • GNFT 1999
  • JFIN 2011
  • Country
  • GNFT France
  • JFIN China
  • Employees
  • GNFT N/A
  • JFIN N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • JFIN Finance: Consumer Services
  • Sector
  • GNFT Health Care
  • JFIN Finance
  • Exchange
  • GNFT Nasdaq
  • JFIN Nasdaq
  • Market Cap
  • GNFT 296.4M
  • JFIN 352.7M
  • IPO Year
  • GNFT 2019
  • JFIN 2019
  • Fundamental
  • Price
  • GNFT $4.23
  • JFIN $6.21
  • Analyst Decision
  • GNFT Strong Buy
  • JFIN
  • Analyst Count
  • GNFT 1
  • JFIN 0
  • Target Price
  • GNFT $13.00
  • JFIN N/A
  • AVG Volume (30 Days)
  • GNFT 7.5K
  • JFIN 50.0K
  • Earning Date
  • GNFT 09-19-2024
  • JFIN 11-20-2024
  • Dividend Yield
  • GNFT N/A
  • JFIN 14.49%
  • EPS Growth
  • GNFT N/A
  • JFIN N/A
  • EPS
  • GNFT 0.47
  • JFIN N/A
  • Revenue
  • GNFT $86,225,222.00
  • JFIN $854,955,021.00
  • Revenue This Year
  • GNFT $155.44
  • JFIN N/A
  • Revenue Next Year
  • GNFT N/A
  • JFIN N/A
  • P/E Ratio
  • GNFT $8.98
  • JFIN $1.99
  • Revenue Growth
  • GNFT 175.45
  • JFIN 21.87
  • 52 Week Low
  • GNFT $3.08
  • JFIN $4.00
  • 52 Week High
  • GNFT $6.42
  • JFIN $8.58
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 27.92
  • JFIN 44.35
  • Support Level
  • GNFT $4.17
  • JFIN $5.18
  • Resistance Level
  • GNFT $4.45
  • JFIN $6.38
  • Average True Range (ATR)
  • GNFT 0.14
  • JFIN 0.36
  • MACD
  • GNFT -0.10
  • JFIN -0.05
  • Stochastic Oscillator
  • GNFT 3.66
  • JFIN 61.38

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital + technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

Share on Social Networks: